Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Organon & Co. | 62,702.65 | reported | 13 Jun 2025 | tx 5+58,040.93 |
| Fulcrum Therapeutics, Inc. | 36,000 | reported | 26 Jun 2025 | tx 9+159,999−500 |
| Septerna, Inc. | 16,623 | reported | 17 Jun 2025 | tx 5+116,623 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jun 2025 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 36,000 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Septerna, Inc. | 16,623 | 0.00 USD | deriv |
| 13 Jun 2025 | GRANT_AWARD | Organon & Co. | 23,904.38 | 10.04 USD | deriv |
| 07 Mar 2025 | PURCHASE | Septerna, Inc. | 13,319 | 6.93 USD | |
| 04 Mar 2025 | PURCHASE | Septerna, Inc. | 7,491 | 6.35 USD | |
| 05 Mar 2025 | PURCHASE | Septerna, Inc. | 37,835 | 5.82 USD | |
| 06 Mar 2025 | PURCHASE | Septerna, Inc. | 41,355 | 6.00 USD | |
| 17 Jun 2024 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Organon & Co. | 9,638.55 | 20.75 USD | deriv |
| 27 Jun 2023 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 09 Jun 2023 | GRANT_AWARD | Organon & Co. | 10,086 | 19.83 USD | deriv |
| 28 Jun 2022 | OTHER | Fulcrum Therapeutics, Inc. | 500 | 0.00 USD | deriv |
| 27 Jun 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | Organon & Co. | 5,640 | 35.46 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | Organon & Co. | 8,772 | 36.05 USD | deriv |
| 03 Dec 2020 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 11 Jun 2020 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 9,285 | 0.00 USD | deriv |
| 18 Jul 2019 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 5,714 | 0.00 USD | deriv |